Contribution: Industrial Research Assistance Program – Contributions to Firms
Nucliq Biologics Inc.
$248,643.00
Gut Health Check Kit Design, Development and Report Production using Artificial Intelligence
FY 2021-22 · 2021-05-03
Summary
Digestive disorders are observed in 20 million Canadians every year. Moreover, it costs 18 bn dollars to the Canadian
economy in terms of medical expenses and loss of productivity. Nucliq Biologics Inc (NBI) incorporated in April 2019 provides services to reveal the gut microbial diversity for the patients suffering with dysbiosis (gut microbial imbalance), gastrointestinal problems, obesity and other gut related diseases. NBI performs tests to uncover the gut microbiome and provides a detailed clinical report and counselling related to gut health, food, nutrition and bacterial composition to improve patient’s health.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
St. John's|St. John's, Newfoundland and Labrador, Canada
Recipient Type
For-profit organization
Business Number
755204930
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-05-03 | 2021-22 | $130,560.00 |
| 2 | 2021-05-03 | 2021-22 | $216,219.00 |
| 3 | 2021-05-03 | 2021-22 | $248,643.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 32,424 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 32 424 dollars.
Agreement End Date
2023-03-31
Agreement Number
972314
Agreement Start Date
2021-05-03
Agreement Title
Gut Health Check Kit Design, Development and Report Production using Artificial Intelligence
Agreement Title (French)
Conception, élaboration et production de rapports sur le kit de contrôle de la santé intestinale à l'aide de l'intelligence artificielle
Agreement Type
Contribution
Agreement Value
$248,643.00
Amendment Date
2022-10-28
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Digestive disorders are observed in 20 million Canadians every year. Moreover, it costs 18 bn dollars to the Canadian
economy in terms of medical expenses and loss of productivity. Nucliq Biologics Inc (NBI) incorporated in April 2019 provides services to reveal the gut microbial diversity for the patients suffering with dysbiosis (gut microbial imbalance), gastrointestinal problems, obesity and other gut related diseases. NBI performs tests to uncover the gut microbiome and provides a detailed clinical report and counselling related to gut health, food, nutrition and bacterial composition to improve patient’s health.
Description (French)
Les troubles digestifs sont observés chez 20 millions de Canadiens chaque année. De plus, ils coûtent 18 milliards de dollars à l'économie canadienne au niveau des frais médicaux et de la perte de productivité. Nucliq Biologics Inc. (NBI) incorporé en avril 2019 fournit des services pour révéler la diversité microbienne intestinale pour les patients souffrant de dysbiose (déséquilibre microbien intestinal), de problèmes gastro-intestinaux, d'obésité et d'autres maladies liées à l'intestin. NBI effectue des tests pour découvrir le microbiome intestinal et fournit un rapport clinique détaillé et des conseils liés à la santé intestinale, à l'alimentation, à la nutrition et à la composition bactérienne pour améliorer la santé du patient.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
St. John's East
Federal Riding (French)
St. John's-Est
Federal Riding Number
10006
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
755204930
Recipient City
St. John's|St. John's
Recipient Country
CA
Recipient Legal Name
Nucliq Biologics Inc.
Recipient Operating Name
Nucliq Bio
Recipient Postal Code
A1B 4B8
Recipient Province or Territory
NL
Recipient Type
F
Reference Number
172-2021-2022-Q1-972314